Abstract
The insertion of gold nanoparticles in biological liquids, tissues and organs permits to increase the equivalent atomic number of the medium that, if used as target to be irradiated by ionizing radiation, permits an increment of the absorbed dose. No toxic nanoparticles, such as the Au, can be injected in the cancer tissues at different concentrations before using a localized treatment that uses energetic proton beams for radiotherapy. Due to the high density and atomic number of the used gold nanoparticles, the absorbed radiation dose can be increased to about a factor six per cent using relatively low concentration of nanoparticles injectable as solution in the tumor tissue. This means to reduce the exposition to ionizing radiation or to increase the dose to the tumor site. Simulation programs of proton energy loss in tissues, using SRIM Code, are employed to evaluate the Bragg peak enhancing in presence of Au nanoparticles, so it will be presented and discussed. Some research findings and patents in the gold nanoparticle preparation and application to Medicine are reviewed in the present paper.
Keywords: Bragg peak, gold nanoparticles, ionizing radiation, protontherapy, radiotherapy, SRIM code.
Recent Patents on Nanotechnology
Title:Gold Nanoparticles Enhancing Protontherapy Efficiency
Volume: 9 Issue: 1
Author(s): Lorenzo Torrisi
Affiliation:
Keywords: Bragg peak, gold nanoparticles, ionizing radiation, protontherapy, radiotherapy, SRIM code.
Abstract: The insertion of gold nanoparticles in biological liquids, tissues and organs permits to increase the equivalent atomic number of the medium that, if used as target to be irradiated by ionizing radiation, permits an increment of the absorbed dose. No toxic nanoparticles, such as the Au, can be injected in the cancer tissues at different concentrations before using a localized treatment that uses energetic proton beams for radiotherapy. Due to the high density and atomic number of the used gold nanoparticles, the absorbed radiation dose can be increased to about a factor six per cent using relatively low concentration of nanoparticles injectable as solution in the tumor tissue. This means to reduce the exposition to ionizing radiation or to increase the dose to the tumor site. Simulation programs of proton energy loss in tissues, using SRIM Code, are employed to evaluate the Bragg peak enhancing in presence of Au nanoparticles, so it will be presented and discussed. Some research findings and patents in the gold nanoparticle preparation and application to Medicine are reviewed in the present paper.
Export Options
About this article
Cite this article as:
Torrisi Lorenzo, Gold Nanoparticles Enhancing Protontherapy Efficiency, Recent Patents on Nanotechnology 2015; 9 (1) . https://dx.doi.org/10.2174/1872210509999141222224121
| DOI https://dx.doi.org/10.2174/1872210509999141222224121 |
Print ISSN 1872-2105 |
| Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
Call for Papers in Thematic Issues
Advances in Vanadium and Titanium Resources for High-performance Materials via Nanostructuring and Nanoengineering
Vanadium and titanium-based materials are ideal candidates for structural and functional materials in aerospace, biomedical engineering, optics, catalysis, energy storage and conversion etc. Vanadium/titanium-based alloys, compounds and materials have a large family with different chemical compositions, dimensions, structures/morphologies, and chemical/physical/mechanical properties, which provides huge opportunities for the development of emerging ...read more
Endogenous and Exogenous Responsive Nanocarriers for Disease Theranostics
Smart nanoplatforms with endogenous- and exogenous-responsiveness have been developed in biomedical applications, such as pH, redox, enzyme, hypoxia, light, ultrasound, radiation, electricity, magnetism, heat, etc. These smart nanocarriers can be effectively delivered by overcoming various barriers in vivo and achieve stimuli-responsive drug/gene release in targeted tissues, thus realizing the enhanced ...read more
Nanotechnology Emphasis on Novel Multifunctional Nanomaterials and Advanced Manufacturing for Applications in Science and Engineering
Nanotechnology and material science play key roles in the intrinsically multidisciplinary subject of Multifunctional Nanomaterials, Advanced Manufacturing, and Interfaces. Because of their unique qualities, these materials—which set them apart from their bulk counterparts—find use in a variety of industries, including aerospace, automotive, electronics, medical, energy, and materials engineering. They have ...read more
Related Journals
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design Editorial (Thematic Issue: Study and Prediction of Pharmacokinetic Drug-Drug Interactions)
Current Drug Metabolism Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Current Medicinal Chemistry <sup>99m</sup>Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
Current Radiopharmaceuticals Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Current Medicinal Chemistry Baicalin Induces Apoptosis of Gallbladder Carcinoma Cells in vitro via a Mitochondrial-Mediated Pathway and Suppresses Tumor Growth in vivo
Anti-Cancer Agents in Medicinal Chemistry Shear Stress-sensitive Carriers for Localized Drug Delivery
Current Pharmaceutical Design Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments
Current Drug Metabolism Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation
Protein & Peptide Letters Targeting Carcinogen Metabolism by Dietary Cancer Preventive Compounds
Current Cancer Drug Targets General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination
Current Gene Therapy A Review on the Techniques for Characterizing and Predicting Human Genomic DNA Methylation
Current Bioinformatics Oxaliplatin for Colorectal Cancer Therapy: A Review
Clinical Cancer Drugs Is There a Place for Drug Combination Strategies Using Clinical Pharmacology Attributes? – Review of Current Trends in Research
Current Clinical Pharmacology Microdialysis in Drug Discovery
Current Drug Discovery Technologies Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review
Current Bioactive Compounds Editorial
Current Medical Imaging





